HealthQuill Samsung Biologics
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
Drugs Health Pharma

CDMO Samsung Biologics signs $1.24 billion drug manufacturing deal

Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.

Read More
Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, has inked two deals worth $897 million with Pfizer to make the US-based company’s products.
Drugs Health Pharma

Samsung Biologics inks $879 million deal with Pfizer to make drugs

HQ Team July 4, 2023: Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, has inked two deals worth $897 million.

Read More